718O - PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
| Autor: | de Bono, J.S., De Giorgi, U., Massard, C., Bracarda, S., Nava Rodrigues, D., Kocak, I., Font, A., Arija, J. Arranz, Shih, K., Radavoi, G.D., Yu, W., Chan, W., Gendreau, S., Zhang, L., Riisnaes, R., Wongchenko, M.J., Maslyar, D., Jinga, V. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi243-vi243 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|